Estrogen replacement, aging, and cell-mediated immunity after injury

Area of Science:

• Immunology
• Gerontology
• Trauma Research

Background:

• Aged individuals exhibit poorer outcomes after traumatic injury, characterized by increased immunosuppression and elevated proinflammatory cytokines like interleukin-6 (IL-6).
• Previous studies indicated higher IL-6 levels in aged mice post-injury compared to younger counterparts.
• Estrogen is known to enhance immune responses and reduce IL-6 production.

Purpose of the Study:

• To investigate the effect of estrogen replacement on cellular immunity and proinflammatory cytokine production in aged female mice after burn injury.
• To determine if estrogen therapy can improve survival rates in aged mice subjected to traumatic injury.

Main Methods:

• Aged female mice were subjected to a moderate scald injury.
• Groups received either placebo or estrogen supplementation prior to injury.
• Delayed-type hypersensitivity response and circulating IL-6 levels were measured post-injury.
• Survival rates were monitored in both treatment groups.

Main Results:

• Estrogen treatment partially restored the delayed-type hypersensitivity response, reducing suppression from >75% to 40%.
• Circulating IL-6 levels were reduced by nearly 50% in estrogen-treated aged mice compared to placebo.
• Estrogen replacement significantly increased survival rates from 42% to 70% in aged, burn-injured mice.

Conclusions:

• Estrogen replacement therapy can partially restore cellular immunity and attenuate IL-6 elevation in aged mice after burn injury.
• Estrogen therapy significantly improves survival outcomes in aged mice following traumatic injury.
• Findings suggest potential for age- and gender-specific therapies in trauma patient management.